How to Use Drug Sales Data to Refine Your Channel Strategy and Improve Your Portfolio Management
Historic drug sales data can help with market sizing. By examining sales trends over time you can gauge the attractiveness […]
Insights
How to Use Drug Price Data for Generic Entry Portfolio Management and Prioritization
In evaluating generic entry opportunities many factors must be considered. DrugPatentWatch has comprehensive resources to aid in evaluating patent and
How to Use Drug Price Data for Generic Entry Portfolio Management and Prioritization Read Post »
Inside the mind of an EPO examiner
This article was originally published by Philippe Lahorte in World Patent Information Volume 54, Supplement, September 2018, Pages S18-S22 Under
DrugPatentWatch Partners with Adis: Helping Drug Companies Make Better Decisions
DrugPatentWatch, a provider of global biopharmaceutical business intelligence, has entered into a partnership with Adis. The partner will enhance Adis’
DrugPatentWatch Partners with Adis: Helping Drug Companies Make Better Decisions Read Post »
Branded Generics: What They Are and Why They’re Profitable
Branded generics are generic drugs that have been given proprietary brand names. They have a small, but profitable place in the U.S. pharmaceutical market.
Branded Generics: What They Are and Why They’re Profitable Read Post »
How Pharmaceutical Life Cycle Management Strategies Are Evolving
Pharmaceutical life cycle management begins earlier and ends later to maximize stakeholder value in all phases of drug development.
How Pharmaceutical Life Cycle Management Strategies Are Evolving Read Post »
![Fig 2. Sales for 8 medication-device combination products in 100-top sellers in the US from 2011–2013 [22]](https://www.drugpatentwatch.com/blog/wp-content/uploads/2019/03/Fig-2.-Sales-for-8-medication-device-combination-products-in-100-top-sellers-in-the-US-from-2011–2013-22-1024x1022.png)
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?
This paper was originally published by Reed F. Beall, Jason W. Nickerson, Warren A. Kaplan, Amir Attaran in PLoS ONE
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products? Read Post »
Rising Drug Prices: How Healthcare Systems Are Coping
Healthcare systems including hospitals are taking care-related and business-related steps to cope with rapidly increasing drug prices.
Rising Drug Prices: How Healthcare Systems Are Coping Read Post »
How Companies Can Extract Value from Expired Drug Patents
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
How Companies Can Extract Value from Expired Drug Patents Read Post »
